Does erdafitinib need to be taken long-term?

Erdafitinib is an oral targeted therapy commonly used to treat adult patients with advanced or metastatic urothelial carcinoma (UC). As to whether long-term use of erdafitinib is necessary, multiple factors need to be considered, including the patient's condition, the efficacy and safety of the drug, and the doctor's advice.

1.Severity of disease and treatment effect: For patients with advanced or metastatic UC, usually, the purpose of treatment is to prolong the patient's survival and improve the quality of life. As a targeted therapy, Erdafitinib aims to inhibit the growth and spread of tumors, thereby controlling the disease. If the patient responds well to erdafitinib treatment and the condition is effectively controlled, the doctor may recommend continuing to take the drug long-term to maintain the effect.

2.Efficacy and safety of the drug: Long-term use of erdafitinib requires consideration of its efficacy and safety. In clinical trials, erdafitinib has shown good efficacy in some patients with UC. However, due to factors such as individual differences and drug metabolism, some patients may develop drug tolerance or treatment failure. In addition, erdafitinib may also cause some adverse reactions, such as fatigue, high blood pressure, eye problems, etc. Therefore, doctors need to comprehensively consider the patient's condition and the efficacy and safety of the drug to decide whether to take erdafitinib for a long time.

3.Monitoring and follow-up: For patients receiving erdafitinib, regular monitoring and follow-up are very important. Doctors will regularly check the patient's condition and the effectiveness of the medication, as well as monitor possible adverse reactions. Depending on the patient's condition, the doctor may adjust the medication dosage or take other treatment measures. During the treatment period, patients need to closely cooperate with the doctor's monitoring and follow-up arrangements.

In general, for patients with advanced or metastatic UC, erdafitinib may need to be taken long-term to maintain efficacy. However, the specific need for long-term use of erdafitinib should be determined by the doctor based on the patient's condition, the efficacy and safety of the drug and other factors. Patients need to closely cooperate with doctors for monitoring and follow-up during treatment to ensure maximum efficacy and reduce the occurrence of adverse reactions.